BACH BOLIGCENTER ApS: Financial statements 2026
CVR: 12024584
Source: annual report 2026, Danish Business Authority
01/04/2025 – 31/03/2026
BACH BOLIGCENTER ApS (CVR 12024584) has filed annual accounts for 2026. In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122. The solvency ratio was 93.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -12,635
- Profit/Loss
- DKK 3,958
- Equity
- DKK 243,122
- Total Assets
- DKK 260,950
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2026 | - | -13K | 4K | 243K | 1 |
| 2025 | - | -20K | -36K | 307K | 1 |
| 2024 | - | -20K | 38K | 404K | 1 |
| 2023 | - | -15K | -201K | 424K | 1 |
| 2022 | - | -14K | -153K | 682K | 1 |
Official annual report
Find more companies like BACH BOLIGCENTER ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorAbout BACH BOLIGCENTER ApS
BACH BOLIGCENTER ApS is a Danish company of the type Anpartsselskab based in Hammel, founded in 1988. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named EMBRYODAN ApS. The management consists of Geo Koch. The company is owned by Geo Koch. The company has 1 employee (2023). In 2026, the company reported a gross profit of DKK -12,635 and a net result of DKK 3,958 compared with DKK -35,885 the year before. Equity in the 2026 report amounted to DKK 243,122.
